Log In
Print this Print this

omaveloxolone (oral RTA 408)

  Manage Alerts
Collapse Summary General Information
Company Reata Pharmaceuticals Inc.
DescriptionOleanane triterpenoid that activates nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2) and inhibits NF-kappa B (NF-kB)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2) ; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
Mechanism of ActionNuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2) activator; NF-kappa B (NF-kB) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today